Motohisa Yamamoto Selected Research

Neoplasms (Cancer)

9/2023	Extraction of Characteristic Serum MicroRNAs and Prediction of Target Genes in IgG4-related Dacryoadenitis and Sialadenitis.
1/2023	Positive antiphospholipid antibodies and pulmonary embolism in a patient with adalimumab-induced lupus.
6/2022	Nationwide epidemiological survey of immunoglobulin G4-related disease with malignancy in Japan.
6/2012	Risk of malignancies in IgG4-related disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Motohisa Yamamoto Research Topics

Disease

54	Immunoglobulin G4-Related Disease 05/2024 - 01/2010
15	Fibrosis (Cirrhosis) 01/2022 - 07/2010
15	Mikulicz' Disease 11/2014 - 04/2005
10	Autoimmune Pancreatitis 01/2015 - 04/2005
9	Sialadenitis 09/2023 - 01/2012
8	Dacryocystitis (Dacryoadenitis) 09/2023 - 01/2012
8	Rheumatoid Arthritis 10/2020 - 01/2007
7	Interstitial Nephritis (Tubulointerstitial Nephritis) 02/2016 - 01/2006
5	Autoimmune Diseases (Autoimmune Disease) 05/2020 - 01/2013
5	Retroperitoneal Fibrosis 12/2018 - 01/2006
5	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 03/2018 - 10/2005
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 01/2004
4	Neoplasms (Cancer) 09/2023 - 06/2012
4	Rheumatic Diseases (Rheumatism) 05/2023 - 02/2007
4	Inflammation (Inflammations) 01/2022 - 03/2014
3	Arthritis (Polyarthritis) 10/2020 - 02/2004
3	Disease Progression 11/2016 - 10/2013
3	Systemic Scleroderma (Systemic Sclerosis) 01/2016 - 01/2012
3	Autoimmune Hypophysitis 02/2012 - 01/2006
3	Thyroiditis 02/2012 - 01/2006
3	Thrombocytopenia (Thrombopenia) 12/2009 - 01/2004
2	Glucose Intolerance 01/2023 - 10/2005
2	Muscular Atrophy (Muscle Atrophy) 01/2023 - 01/2021
2	Osteonecrosis (Kienbock's Disease) 05/2020 - 01/2013
2	Takayasu Arteritis (Arteritis, Takayasu's) 12/2018 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2018 - 06/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2017 - 01/2016
2	Tuberculosis (Tuberculoses) 01/2016 - 10/2007
2	Hypersensitivity (Allergy) 01/2016 - 12/2009
2	Multi-centric Castleman's Disease 01/2016 - 06/2012
2	Churg-Strauss Syndrome (Allergic Angiitis) 06/2012 - 01/2010
2	Fever (Fevers) 12/2009 - 06/2006
2	Liver Diseases (Liver Disease) 02/2004 - 01/2004
1	Ulcerative Colitis 05/2024
1	COVID-19 05/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Abdominal Obesity 01/2023
1	Pulmonary Embolism 01/2023
1	Hyperinsulinism (Hyperinsulinemia) 01/2023
1	Hyperglycemia 01/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023
1	Obesity 01/2023

Drug/Important Bio-Agent (IBA)

44	Immunoglobulin G (IgG)IBA 01/2022 - 02/2004
18	GlucocorticoidsIBA 05/2023 - 10/2005
15	Immunoglobulins (Immunoglobulin)IBA 06/2022 - 01/2006
10	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020 - 12/2004
9	SteroidsIBA 01/2023 - 02/2004
9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
6	AutoantibodiesIBA 01/2023 - 02/2006
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2007
4	Abatacept (Orencia)FDA Link 10/2020 - 01/2016
4	InterleukinsIBA 09/2019 - 01/2016
3	Rituximab (Mabthera)FDA Link 12/2021 - 08/2015
3	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 07/2009
3	CytokinesIBA 11/2018 - 03/2014
3	Immunoglobulin E (IgE)IBA 03/2018 - 11/2010
3	Infliximab (Remicade)FDA Link 10/2007 - 06/2006
3	Antinuclear AntibodiesIBA 10/2005 - 01/2004
2	HLA-DRB1 Chains (HLA DRB1)IBA 05/2023 - 09/2019
2	Antiphospholipid AntibodiesIBA 01/2023 - 01/2015
2	Adalimumab (Humira)FDA Link 01/2023 - 10/2020
2	RNA (Ribonucleic Acid)IBA 05/2020 - 01/2015
2	interleukin-21 (interleukin 21)IBA 11/2018 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 01/2007
2	AntigensIBA 02/2017 - 01/2016
2	Interferon-gamma (Interferon, gamma)IBA 06/2016 - 10/2007
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 01/2012
2	EnzymesIBA 01/2013 - 01/2004
2	TinIBA 10/2011 - 02/2010
2	SS-B antibodiesIBA 07/2010 - 02/2006
1	Janus Kinase InhibitorsIBA 05/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2024
1	Phosphotransferases (Kinase)IBA 05/2024
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2024
1	CalciumIBA 09/2023
1	Non-Receptor Type 3 Protein Tyrosine PhosphataseIBA 09/2023
1	GlypicansIBA 09/2023
1	AcidsIBA 09/2023
1	MicroRNAs (MicroRNA)IBA 09/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2023
1	BNT162 VaccineIBA 05/2023
1	mRNA VaccinesIBA 05/2023
1	Messenger RNA (mRNA)IBA 05/2023
1	CorticosteroneIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	Interleukin-2 (IL2)IBA 01/2022
1	dupilumabIBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	class-I restricted T cell-associated moleculeIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Eicosapentaenoic AcidIBA 01/2021

Therapy/Procedure

17	Therapeutics 05/2023 - 12/2009
3	Aftercare (After-Treatment) 02/2016 - 06/2012
2	Remission Induction 05/2023 - 12/2021
2	Precision Medicine 05/2023 - 03/2018
1	Drug Tapering 05/2024